Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cerebra is a Canadian digital health and sleep diagnostics company focused on improving sleep assessment and the diagnosis and treatment of sleep disorders. Its core commercial offering is the Cerebra Sleep System, an in-home, self-applied polysomnography platform that uses patented Odds Ratio Product (ORP) technology to provide a continuous measure of sleep depth beyond conventional sleep scoring. The company positions its technology for researchers, clinicians, and sleep innovators seeking more personalized and data-rich sleep analysis. Cerebra also licenses and distributes sleep-related technologies and programs, including digital biomarkers and a cognitive behavioral therapy program for insomnia. Overall, the company operates as a commercial-stage sleep technology business rather than a therapeutic drug developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cerebra.